Edgewise Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2020 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Edgewise Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q3 2024.
  • Edgewise Therapeutics, Inc. Depreciation for the quarter ending September 30, 2024 was $500K, a 25% increase year-over-year.
  • Edgewise Therapeutics, Inc. Depreciation for the twelve months ending September 30, 2024 was $2.03M, a 87.9% increase year-over-year.
  • Edgewise Therapeutics, Inc. annual Depreciation for 2023 was $1.55M, a 321% increase from 2022.
  • Edgewise Therapeutics, Inc. annual Depreciation for 2022 was $368K, a 35.3% increase from 2021.
  • Edgewise Therapeutics, Inc. annual Depreciation for 2021 was $272K, a 47% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.03M $500K +$100K +25% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $1.93M $500K +$100K +25% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $1.83M $473K +$278K +143% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $1.55M $556K +$471K +554% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-22
Q3 2023 $1.08M $400K +$300K +300% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $780K $400K +$300K +300% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $480K $195K +$112K +135% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $368K $85K +$43K +102% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-22
Q3 2022 $325K $100K $0 0% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $325K $100K +$49K +96.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $276K $83K +$4K +5.06% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 $272K $42K -$8K -16% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 $280K $100K +$51K +104% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $229K $51K +$5K +10.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $224K $79K +$39K +97.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q4 2020 $185K $50K Oct 1, 2020 Dec 31, 2020 10-K 2022-02-24
Q3 2020 $49K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $46K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $40K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.